53,000-square-foot facility addresses unique demands of commercial-scale viral vector production COSTA MESA, Calif., June 16, 2022 /PRNewswire/ -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated ...

Avid’s expansion into viral vector development and manufacturing is driven by continued strong growth in the cell and gene therapy market combined with the CDMO industry’s overall lack of ...

We now look forward to engaging in a meaningful way with potential viral vector clients and offering this latest tangible evidence of the quality of Avid’s facilities and the capabilities of our ...

ft. viral vector development and CGMP manufacturing facility in Costa Mesa, CA, approximately five miles from Avid’s existing operations in Tustin, CA. Additionally, Avid has appointed Drew ...

(MENAFN- EIN) Academy Color Encoding System welcomes creator of Avid media Composer nonlinear editing system as inaugural member of Editorial Finishing logo product category LAS VEGAS, April 06 ...

Under the Tech & Innovation risk category, Avid noted that it is expanding its CDMO service into viral vector development and manufacturing services for the cell and gene therapy market.

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites. Avid Bioservices, a biologics-focused contract ...

The company built a 53,000 ft 2 space dedicated to viral vector manufacturing to continue providing innovation. Intephex introduced Avid to SteraMist and ionized Hydrogen Peroxide (iHP ...

it has been nothing short of remarkable for Avid and CRB to be opening the doors of Avid’s new viral vector process development labs here in June.” The state-of-the-art facility at full build-out will ...

COSTA MESA, Calif., June 16, 2022 /PRNewswire/ -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP ...